This study is in progress, not accepting new patients
A Study to Evaluate The Efficacy And Safety Of RO7198457 In Combination With Pembrolizumab Versus Pembrolizumab Alone In Participants With Previously Untreated Advanced Melanoma.
a study on Melanoma Skin Cancer/Melanoma
- for people ages 18 years and up (full criteria)
- at San Francisco, California and other locations
- study startedestimated completion
Advanced Melanoma, Melanoma, Pembrolizumab
- in progress, not accepting new patients
- Start Date
- Completion Date
- Genentech, Inc.
- Phase 2 research study
- Study Type
- About 131 people participating
- Last Updated